Surveillance and Analysis of SARS-CoV-2 Variant Importation - China, January-June 2022.

Feng, Yenan; Zhao, Xiang; Yin, Zeyuan; Wu, Changcheng; Chen, Zhixiao; Nie, Kai; A, Ruhan; Li, Lili; Niu, Peihua; Wang, Ji; Wu, Yuchao; Wang, Shiwen; Wang, Dayan; Tan, Wenjie; Wang, Huanyu; Ma, Xuejun; Gao, George F; Chen, Cao; Xu, Wenbo

Feng, Yenan; Zhao, Xiang; Yin, Zeyuan; Wu, Changcheng; Chen, Zhixiao; Nie, Kai; A, Ruhan; Li, Lili; Niu, Peihua; Wang, Ji; Wu, Yuchao; Wang, Shiwen; Wang, Dayan; Tan, Wenjie; Wang, Huanyu; Ma, Xuejun; Gao, George F; Chen, Cao; Xu, Wenbo.

Afiliação

Feng Y; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhao X; National Health Commission Key Laboratory for Medical Virology and Viral Diseases, Beijing, China.
Yin Z; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Wu C; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Chen Z; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Nie K; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
A R; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Li L; National Health Commission Key Laboratory for Medical Virology and Viral Diseases, Beijing, China.
Niu P; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Wang J; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Wu Y; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Wang S; National Health Commission Key Laboratory for Medical Virology and Viral Diseases, Beijing, China.
Wang D; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Tan W; National Health Commission Key Laboratory for Medical Virology and Viral Diseases, Beijing, China.
Wang H; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Ma X; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Gao GF; National Health Commission Key Laboratory for Medical Virology and Viral Diseases, Beijing, China.
Chen C; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Xu W; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

China CDC Wkly ; 4(50): 1136-1142, 2022 Dec 16.

Article em En | MEDLINE | ID: mdl-36751558

Palavras-chave

Genomic surveillance; Omicron; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Revista: China CDC Wkly Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google